• Customer portal
logo logo
  • Our solutions
    • Medical Imaging
    • Our products
    • 2D Ultrasound
    • 3D/4D Ultrasound
    • Radiography
    • MRI
    • Veterinary
  • Technology
    • Our technology
    • Research & Development
    • The GOP technology
    • Artificial intelligence
  • News
    • News
    • Media kit
  • Investors
    • Investor news
    • Webcast
    • Financial calendar
    • Financial reports
    • Corporate governance
    • Company overview
    • The share
    • Subscription
    • Media kit
  • Company
    • About ContextVision
    • Leadership Team
    • Board of directors
    • Career
    • ContextVision quality policy
  • Contact
    • Sales
    • Customer Support
    • Headquarters
    • Investor relations & Media
  • HEJ!
    • Research & Development
    • Artificial intelligence
    • The GOP technology
logo logo
  • Our solutions
  • State-of-the-art portfolio
  • 2D Ultrasound
  • 3D/4D Ultrasound
  • Radiography
  • Magnetic Resonance Imaging
  • Veterinary
  • Technology
    • Our technology
    • The GOP technology
    • Research & Development
    • Artificial intelligence
  • News
    • Latest news
    • Media kit
  • Investors
    • Latest investor news
    • Investor news
    • Webcast
    • Financial reports
    • Corporate governance
    • Company overview
    • The share
    • Subscription
    • Media kit
  • Company
    • About
    • Leadership Team
    • Board of Directors
    • Career
    • ContextVision quality policy
  • Contact
  • Customer Portal
Digital Pathology In The Media2020-12-05

An AI-based tool to identify cancer areas in lung biopsies

An AI-based tool to identify cancer areas in lung biopsies
https://www.esp-congress.org/scientific-programme/online-programme.html#!/details/abstract/963
Previous ContextVision Drives Medical Image Enhancement Innovation
Next ContextVision announces signed contract with Vall d’Hebron for clinical evaluation of INIFY® Prostate Screening
© ContextVision AB (publ)